Merrion Pharmaceuticals has said that Jonathan O'Connell will step down as chief executive of the company at the end of June.
He will be replaced by the current chairman, Michael Donnelly, who will become executive chairman on June 30th.
O'Connell took over as chief executive last May and has guided the company through a strategic review and restructuring.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team